August 27, 2026
Three straight years of falling sales, a 3.8x leverage ratio, and a Q1 warning: the yield is real, but so is the risk.
Hey there, bargain hunter. When a stock yields nearly 7% and owns Absolut, Jameson, Chivas Regal, and Martell, your first instinct is to reach for the buy button. Hold off. This morning Pernod Ricard reported its third consecutive year of falling sales, warned that its two biggest markets will drag into the new fiscal quarter, and quietly trimmed its medium-term growth ambitions. That is not the setup for a reflexive value call.
Scoreboard
Pernod reported a worse-than-expected 3.9% organic sales decline in fiscal year 2026, hit by persistent weak demand in the U.S. and China and disruption to tourism from a prolonged conflict in the Middle East. Overall group sales reached €9.4 billion in the 12 months to June 30, 2026, and the 3.9% organic contraction was worse than the 3.7% analysts had expected. Profit from recurring operations came in at €2.42 billion, an organic decline of 5.2%, though that beat the 5.9% fall the consensus had penciled in.
Sales declined 14% in the United States and 19% in China as a weak economic climate and regulatory measures hit demand for prestige brands, notably Martell cognac.
The Real Problem
This was Pernod Ricard’s third consecutive year of sales decline, and recovery prospects for the fiscal year that started July 1 look muted. The market had been told H2 FY26 would show improving trends. By the Q3 update in April 2026, full-year organic net sales guidance had already been cut to a decline of 3% to 4%, citing the ongoing conflict in the Middle East. The final number came in worse than even that revised range.
Your Free Options Book Is About to Vanish
In case you missed it… make sure you get your free “Simple Options Trading For Beginners” book before your link expires.
I eventually plan to charge money for this training, so do yourself a favor and download it now…
That way, no matter what it costs in the future, you’ll have a free copy.
Sound good?
For fiscal Q1 FY27, Pernod predicted organic net sales to be broadly stable, with U.S. and Chinese markets still hit by inventory adjustments. The company also trimmed its medium-term sales growth guidance, now projecting organic net sales growth to be, on average, close to the lower end of its +3% to +6% range over FY27 to FY29. That is a meaningful concession.
The Business
Pernod owns 17 of the top 100 premium spirits brands, with over 240 premium brands distributed across more than 160 markets. Revenue comes from brand premiums on aged liquids: Martell cognac, Chivas Regal, The Glenlivet, Jameson Irish whiskey, Absolut vodka. The model works beautifully in a growth cycle. In a simultaneous US and China downturn, it concentrates pain fast.
Data That Matters
- FY26 group organic sales: -3.9% (vs. -3.7% expected)
- Profit from recurring operations: €2.42bn, -5.2% organic
- Net debt/EBITDA ratio at 3.8x as of December 31, 2025, reflecting lower EBITDA including FX headwinds.
- The company aims to bring net debt/EBITDA below 3x by FY29.
- Dividend proposed at €4.70 per share (stable vs FY25, subject to shareholder approval).
- Payout ratio running at approximately 85%.
A payout ratio above 85% on a declining earnings base, sitting behind about €11.2 billion of net debt as of December 31, 2025, is the number that deserves the most scrutiny here. High leverage at net debt/EBITDA of 3.8x and looming refinancing needs heighten risk, with a potential dividend cut and further operational disappointments as key negative catalysts.
The biggest change to American money since 1974?
Two executive orders signed on June 22 barely made the news. But they may have triggered the biggest shift in U.S. money policy in decades. One little-known $20 company is suddenly at the center of it all.
Is It Cheap?
Pernod’s normalized price/earnings ratio sits around 10x, with a trailing dividend yield near 6.8% to 6.9%. Brown-Forman, for comparison, trades at roughly 16x earnings. On a headline multiple, Pernod looks like the bargain of the sector. But that multiple assumes earnings stabilize. With three years of organic declines and a Q1 warning, that assumption is doing heavy lifting.
Bull / Base / Bear
Bull: China restocking begins in Q2 FY27 as the anti-dumping investigation overhang clears and duty-free cognac sales resume. US inventory normalization runs its course. Markets outside the US and China were growing strongly at 5% in Q3. The rest of the world is working.
Base: Recovery is slow and uneven. The company delivers its €1 billion efficiency program and keeps leverage drifting down, but medium-term organic growth lands closer to 3% than 6%. The dividend holds, barely.
Wall Street Is Waiting for Washington’s Next Crypto Move
The CLARITY Act could reshape how major financial institutions participate in crypto. And while firms like Goldman Sachs, J.P. Morgan and Citadel are already active across digital assets, our team believes one little-known altcoin could stand out as clearer rules bring more institutional capital on-chain.
Discover the overlooked altcoin we believe could benefit from crypto’s next regulatory chapter.
Bear: A fourth year of declines breaks the payout. Premium spirits are more cyclical than most other consumer staples categories, and volume can suffer steeper declines in economic downturns. A dividend cut, combined with 3.8x leverage, resets the stock well below today’s price.
Action Plan
Do not chase the yield. Watch two triggers before adding: net debt/EBITDA moving decisively below 3.5x, and two consecutive quarters of positive US organic sell-out. Neither condition is met today. If you already own it, hold and monitor the Q1 FY27 read in October. If you are sizing in fresh, keep position small and leave room to average.
Cheap Investor Checklist
- Net debt/EBITDA trending toward below 3x by FY29: target set, not yet in motion
- US organic sell-out turning positive: not confirmed
- China cognac duty-free sales resuming from Q2: management expectation, unverified
- Payout ratio declining below 75%: needs earnings recovery first
- Dividend proposed at €4.70: confirmed for FY26 (subject to shareholder approval)
- Efficiency program on track: one-third of €1bn target expected by FY26 end
- Free cash flow conversion above 80%: targeted and partially delivered
- Medium-term guidance revised to lower end of 3-6% range: confirmed
- RTD and small-format growth offsetting premium weakness: early positive signal
- Q1 FY27 organic sales: the next hard data point, due October
Bottom Line
If leverage comes down and China turns before the dividend breaks, Pernod at 10x earnings is genuinely cheap. If earnings keep sliding and the payout ratio pushes above 90%, the yield is a trap. The brands are durable. The balance sheet is not yet comfortable. Watch the debt ratio, not the dividend yield, to time this one.
